Logo of Annexon Biosciences

Remote Jobs at Annexon Biosciences

Developing complement medicines

Neurodegeneration
Autoimmune
Ophthalmology

About Annexon Biosciences

Annexon Biosciences (Nasdaq: ANNX) is a clinical-stage biopharmaceutical company focused on developing complement medicines for autoimmune, neurodegenerative, and ophthalmic disorders. The company’s innovative pipeline includes ANX005, ANX007, and ANX009, targeting the classical complement pathway. Annexon employs a biomarker-driven strategy to enhance the success of its portfolio.

Established

2011

Company Size

51-200 employees

Found Jobs (11)